Join the Swiss diabetes registry study for adults
Part of Hormones & metabolism clinical trials.
This study keeps a registry (a secure list) of adults with diabetes. It collects information over time to better understand diabetes and support care—your participation is voluntary.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have a diabetes diagnosis (not gestational diabetes)
- Be able to understand the study and sign informed consent
- Not have gestational diabetes
- Have enough health/life expectancy of at least about 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps create and manage a diabetes patient database. It may help future research by collecting information from adult patients who agree to participate.
This study collects information about people with diabetes to better understand the condition in everyday life. It may help improve future diabetes care by building a real-world diabetes database.
This study sets up a diabetes registry, which means collecting information about people’s diabetes care in a hospital clinic. It may help improve understanding of how diabetes is managed in real life, which can support better future care.
This registry study collects health information from people with diabetes to help researchers better understand and improve diabetes care in Taiwan. It involves no new treatments or procedures.
This study records health information to understand how type 2 diabetes and newly diagnosed heart disease affect people over time. It may help doctors learn what to watch for and how to plan care, though it is mainly an observational registry.
This registry enrolls people with a confirmed diagnosis of multiple sclerosis (MS) who are age 18 or older and live in Switzerland (or receive their MS care there). It helps researchers better understand MS in the Swiss population and may improve future studies and care.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.